Quick Takeaways
- PRCT - PROCEPT BioRobotics Corp has 18 insiders with reported activity on this page.
- Net insider value flow over the last year: +$30,573.
- Recent transaction rows are available for direct filing-level review.
- Info
- Insider Trading
- Financials
- Holders
Insider Transactions Reported by 18 Insiders of PROCEPT BioRobotics Corp
- Symbol
- PRCT on Nasdaq
- Location
- San Jose, CA
What Changed
- Buy value: $11,268,081; sell value: $11,237,507.
- Net share flow: +253,033.
Why This Matters
- This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
- Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.
Official SEC Source
Insider trading overview
Last 12 monthsNet insider flow leans to buying over the last 12 months. Net value: +$30,573.
Buys
$11,268,081
Shares: 446,262
Insiders: 2
Sells
$11,237,508
Shares: 193,229
Insiders: 4
Net
+$30,573
Shares: +253,033
Insiders: -2
| Window (months) | Buy shares | Sell shares | Buy $ | Sell $ | Net $ |
|---|---|---|---|---|---|
| 0-3 | 426,262 | 23,229 | $10,482,943 | $573,517 | +$9,909,426 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 20,000 | 0 | $785,138 | $0 | +$785,138 |
| 9-12 | 0 | 170,000 | $0 | $10,663,991 | -$10,663,991 |
PROCEPT BioRobotics Corp executives and other stock owners filed with the SEC include:
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| CPMG Inc | 10%+ Owner | $490,969,607 | Mixed | 17 Mar 2022 | ||
| R. Kent Jr. McGaughy | 10%+ Owner | $242,100,658 | Mixed | 03 May 2024 | ||
| Frederic H. Moll | Director | $33,884,946 | +$785,138 | +2.4% | Filing P/S | 13 Aug 2025 |
| VIKING GLOBAL INVESTORS LP | 10%+ Owner | $13,409,444 | Mixed | 18 Mar 2022 | ||
| Antal Rohit Desai | Director | $12,257,125 | +$1,101,590 | +9.9% | Mixed | 05 Mar 2026 |
| Larry L. Wood | President, CEO, Director | $8,942,792 | Mixed | 05 Mar 2026 | ||
| Taylor C. Harris | Director | $7,141,536 | Mixed | 10 Jun 2025 | ||
| Ph.D. Reza Zadno | President, CEO, Director | $5,741,081 | Mixed | 09 May 2025 | ||
| Morgan Colby Wood | Director | $5,077,621 | Mixed | 13 Nov 2023 | ||
| Hisham Shiblaq | EVP, Chief Comm. Officer | $4,670,471 | -$1,282,637 | -22% | Mixed | 06 Jun 2025 |
| Kevin Waters | Evp, Cfo | $4,354,212 | -$179,177 | -4% | Mixed | 17 Mar 2026 |
| Thomas M. Krummel | Director | $3,021,847 | Mixed | 04 Jun 2024 | ||
| Alaleh Nouri | Evp, Clo, Corp. Sec. | $2,873,574 | -$394,340 | -12% | Mixed | 19 Mar 2026 |
| Mary Garrett | Director | $775,506 | Mixed | 10 Jun 2025 | ||
| Elisabeth Sandoval Little | Director | $678,633 | Mixed | 10 Jun 2025 | ||
| Amy M. Dodrill | Director | $416,535 | Mixed | 10 Jun 2025 | ||
| Thomas M. Prescott | Director | $225,680 | Mixed | 10 Jun 2025 | ||
| Dan Puckett | Director | $156,066 | Mixed | 05 Mar 2026 |
Top shareholders of PROCEPT BioRobotics Corp (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| CPMG Inc |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
10,918,394
|
$490,969,607 | — | 17 Mar 2022 | |
| R. Kent Jr. McGaughy |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
3,780,460
|
$242,100,658 | — | 03 May 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
9.4%
|
5,202,306
|
$163,664,546 | — | 31 Dec 2025 | |
| FMR LLC |
13F
13D/G
|
Company |
2.9%
from 13D/G
|
4,653,111
|
$146,386,864 | — | 31 Dec 2025 | |
| BlackRock, Inc. |
13F
|
Company |
7.8%
|
4,347,033
|
$136,757,659 | — | 31 Dec 2025 | |
| ALLIANCEBERNSTEIN L.P. |
13D/G
13F
|
Company |
6.1%
|
3,419,784
|
$122,052,091 | $0 | 30 Sep 2025 | |
| T. Rowe Price Investment Management, Inc. |
13F
13D/G
|
Company |
5.9%
from 13D/G
|
3,271,408
|
$102,919,000 | — | 31 Dec 2025 | |
| BNP Paribas Asset Management Holding S.A. |
13F
13D/G
|
Company |
5.5%
from 13D/G
|
3,094,649
|
$97,357,000 | — | 31 Dec 2025 | |
| MACKENZIE FINANCIAL CORP |
13F
|
Company |
2.8%
|
1,573,405
|
$49,511,860 | — | 31 Dec 2025 | |
| Artisan Partners Limited Partnership |
13F
|
Company |
2.7%
|
1,520,700
|
$47,841,222 | — | 31 Dec 2025 | |
| STATE STREET CORP |
13F
|
Company |
2.7%
|
1,489,029
|
$46,844,852 | — | 31 Dec 2025 | |
| Champlain Investment Partners, LLC |
13F
|
Company |
2.6%
|
1,441,034
|
$45,334,930 | — | 31 Dec 2025 | |
| Prosight Management, LP |
13F
|
Company |
2.5%
|
1,380,000
|
$43,414,800 | — | 31 Dec 2025 | |
| ArrowMark Colorado Holdings LLC |
13F
|
Company |
2.4%
|
1,349,831
|
$42,465,683 | — | 31 Dec 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.4%
|
1,328,514
|
$41,802,740 | — | 31 Dec 2025 | |
| Chicago Capital, LLC |
13F
|
Company |
2.1%
|
1,190,995
|
$37,468,687 | — | 31 Dec 2025 | |
| Frederic H. Moll |
3/4/5
|
Director |
—
mixed-class rows
|
865,930
mixed-class rows
|
$33,884,946 | +$785,138 | 13 Aug 2025 | |
| UBS Group AG |
13F
|
Company |
1.9%
|
1,052,944
|
$33,125,618 | — | 31 Dec 2025 | |
| BAILLIE GIFFORD & CO |
13F
|
Company |
1.8%
|
1,015,978
|
$31,962,667 | — | 31 Dec 2025 | |
| MORGAN STANLEY |
13F
|
Company |
1.5%
|
843,491
|
$26,536,254 | — | 31 Dec 2025 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1.3%
|
705,740
|
$22,204,000 | — | 31 Dec 2025 | |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. |
13F
|
Company |
1.3%
|
699,971
|
$22,021,088 | — | 31 Dec 2025 | |
| Rhenman & Partners Asset Management AB |
13F
|
Company |
1.1%
|
611,000
|
$19,222,060 | — | 31 Dec 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
1%
|
553,103
|
$17,400,621 | — | 31 Dec 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.93%
|
517,732
|
$16,287,849 | — | 31 Dec 2025 | |
| Bellevue Group AG |
13F
|
Company |
0.93%
|
515,430
|
$16,215,428 | — | 31 Dec 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.83%
|
462,373
|
$14,546,255 | — | 31 Dec 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.78%
|
431,205
|
$13,565,709 | — | 31 Dec 2025 | |
| VIKING GLOBAL INVESTORS LP |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
298,205
|
$13,409,444 | — | 18 Mar 2022 | |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.75%
|
416,243
|
$13,095,005 | — | 31 Dec 2025 | |
| Antal Rohit Desai |
3/4/5
|
Director |
0.86%
|
475,777
mixed-class rows
|
$12,257,125 | +$1,101,590 | 05 Mar 2026 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.7%
|
389,278
|
$12,246,686 | — | 31 Dec 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.69%
|
383,137
|
$12,053,490 | — | 31 Dec 2025 | |
| C WorldWide Group Holding A/S |
13F
|
Company |
0.68%
|
375,000
|
$11,798,000 | — | 31 Dec 2025 | |
| JOHNSON & JOHNSON |
13F
|
Company |
0.64%
|
357,939
|
$11,260,761 | — | 31 Dec 2025 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
0.61%
|
340,841
|
$10,722,471 | — | 31 Dec 2025 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.6%
|
331,205
|
$10,419,709 | — | 31 Dec 2025 | |
| Eagle Health Investments LP |
13F
|
Company |
0.56%
|
308,434
|
$9,703,334 | — | 31 Dec 2025 | |
| Larry L. Wood |
3/4/5
|
President, CEO, Director |
—
mixed-class rows
|
417,031
mixed-class rows
|
$8,942,792 | — | 05 Mar 2026 | |
| Nuveen, LLC |
13F
|
Company |
0.51%
|
282,282
|
$8,880,592 | — | 31 Dec 2025 | |
| Fiera Capital Corp |
13F
|
Company |
0.5%
|
276,494
|
$8,698,501 | — | 31 Dec 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.48%
|
266,476
|
$8,383,335 | — | 31 Dec 2025 | |
| Granite Investment Partners, LLC |
13F
|
Company |
0.48%
|
265,633
|
$8,356,814 | — | 31 Dec 2025 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
0.47%
|
263,227
|
$8,281,121 | — | 31 Dec 2025 | |
| Portolan Capital Management, LLC |
13F
|
Company |
0.46%
|
255,118
|
$8,026,012 | — | 31 Dec 2025 | |
| OSTERWEIS CAPITAL MANAGEMENT INC |
13F
|
Company |
0.43%
|
237,480
|
$7,471,121 | — | 31 Dec 2025 | |
| ExodusPoint Capital Management, LP |
13F
|
Company |
0.43%
|
237,198
|
$7,462,249 | — | 31 Dec 2025 | |
| FRONTIER CAPITAL MANAGEMENT CO LLC |
13F
|
Company |
0.42%
|
234,180
|
$7,367,303 | — | 31 Dec 2025 | |
| Rockefeller Capital Management L.P. |
13F
|
Company |
0.41%
|
228,186
|
$7,178,731 | — | 31 Dec 2025 | |
| Taylor C. Harris |
3/4/5
|
Director |
—
mixed-class rows
|
137,021
mixed-class rows
|
$7,141,536 | — | 10 Jun 2025 |
Recent Insider Transactions by Companies or Individuals for PROCEPT BioRobotics Corp
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Alaleh Nouri | PRCT | Common Stock | Sale | -4.84% | $139,231 | $25.96 | -5,363 | 105,354 | 19 Mar 2026 | Direct |
| Alaleh Nouri | PRCT | Common Stock | Sale | -0.27% | $8,559 | $28.15 | -304 | 110,717 | 17 Mar 2026 | Direct |
| Kevin Waters | PRCT | Common Stock | Sale | -0.46% | $19,876 | $28.15 | -706 | 151,558 | 17 Mar 2026 | Direct |
| Alaleh Nouri | PRCT | Common Stock | Sale | -2.84% | $83,197 | $25.65 | -3,243 | 111,021 | 10 Mar 2026 | Direct |
| Antal Rohit Desai | PRCT | Common Stock | Purchase | 30.1% | $2,422,891 | $24.55 | 98,699 | 426,262 | 09 Mar 2026 | Kestrel Fund, L.P. |
| Antal Rohit Desai | PRCT | Common Stock | Purchase | 95.9% | $3,781,503 | $23.59 | 160,317 | 327,563 | 06 Mar 2026 | Kestrel Fund, L.P. |
| Alaleh Nouri | PRCT | Common Stock | Sale | -5.69% | $163,353 | $23.70 | -6,892 | 114,264 | 06 Mar 2026 | Direct |
| Kevin Waters | PRCT | Common Stock | Sale | -4.23% | $159,300 | $23.70 | -6,721 | 152,264 | 06 Mar 2026 | Direct |
| Antal Rohit Desai | PRCT | Common Stock | Purchase | $4,278,549 | $25.58 | 167,246 | 167,246 | 05 Mar 2026 | Kestrel Fund, L.P. | |
| Larry L. Wood | PRCT | Common Stock | Award | 68.8% | 127,783 | 313,378 | 05 Mar 2026 | Direct | ||
| Larry L. Wood | PRCT | Stock Option (Right to Buy) | Award | 103,653 | 103,653 | 05 Mar 2026 | Direct | |||
| Alaleh Nouri | PRCT | Common Stock | Award | 56.6% | 43,811 | 121,156 | 05 Mar 2026 | Direct | ||
| Alaleh Nouri | PRCT | Stock Option (Right to Buy) | Award | 29,615 | 29,615 | 05 Mar 2026 | Direct | |||
| Kevin Waters | PRCT | Common Stock | Award | 42.6% | 47,462 | 158,985 | 05 Mar 2026 | Direct | ||
| Kevin Waters | PRCT | Stock Option (Right to Buy) | Award | 32,576 | 32,576 | 05 Mar 2026 | Direct | |||
| Dan Puckett | PRCT | Common Stock | Award | 5,476 | 5,476 | 05 Mar 2026 | Direct | |||
| Dan Puckett | PRCT | Stock Option (Right to Buy) | Award | 8,897 | 8,897 | 05 Mar 2026 | Direct | |||
| Alaleh Nouri | PRCT | Common Stock | Award | 6.72% | 4,872 | 77,345 | 19 Feb 2026 | Direct | ||
| Kevin Waters | PRCT | Common Stock | Award | 3.27% | 3,532 | 111,523 | 19 Feb 2026 | Direct | ||
| Larry L. Wood | PRCT | Common Stock | Award | 5694.4% | 182,392 | 185,595 | 02 Sep 2025 | Direct | ||
| Larry L. Wood | PRCT | Stock Option (Right to Buy) | Award | 319,618 | 319,618 | 02 Sep 2025 | Direct | |||
| Mr. Antal Rohit Desai | PRCT | Common Stock | Options Exercise | 318.3% | 26,749 | 35,152 | 14 Aug 2025 | Direct | ||
| Mr. Antal Rohit Desai | PRCT | Stock Option (Right to Buy) | Options Exercise | -100% | -26,749 | 0 | 14 Aug 2025 | Direct | ||
| Alaleh Nouri | PRCT | Common Stock | Options Exercise | 17.9% | 11,000 | 72,473 | 14 Aug 2025 | Direct | ||
| Alaleh Nouri | PRCT | Stock Option (Right to Buy) | Options Exercise | -16.8% | -11,000 | 54,452 | 14 Aug 2025 | Direct | ||
| Frederic H. Moll | PRCT | Common Stock | Purchase | 2.37% | $785,138 | $39.26 | 20,000 | 863,159 | 13 Aug 2025 | Direct |
| Mr. Antal Rohit Desai | PRCT | Common Stock | Sale | -63.5% | $1,537,256 | $61.49 | -25,000 | 14,363 | 12 Jun 2025 | By The 2:22 DNA Trust |
| Mr. Antal Rohit Desai | PRCT | Common Stock | Sale | -38.8% | $1,584,525 | $63.38 | -25,000 | 39,363 | 11 Jun 2025 | By The 2:22 DNA Trust |
| Mr. Antal Rohit Desai | PRCT | Common Stock | Award | 22.4% | 1,538 | 8,403 | 10 Jun 2025 | Direct | ||
| Mr. Antal Rohit Desai | PRCT | Common Stock | Sale | -28% | $1,597,711 | $63.91 | -25,000 | 64,363 | 10 Jun 2025 | By The 2:22 DNA Trust |
| Mr. Antal Rohit Desai | PRCT | Stock Option (Right to Buy) | Award | 2,771 | 2,771 | 10 Jun 2025 | Direct | |||
| Frederic H. Moll | PRCT | Common Stock | Award | 0.18% | 1,538 | 843,159 | 10 Jun 2025 | Direct | ||
| Frederic H. Moll | PRCT | Stock Option (Right to Buy) | Award | 2,771 | 2,771 | 10 Jun 2025 | Direct | |||
| Elisabeth Sandoval | PRCT | Common Stock | Award | 14% | 1,538 | 12,561 | 10 Jun 2025 | Direct | ||
| Elisabeth Sandoval | PRCT | Stock Option (Right to Buy) | Award | 2,771 | 2,771 | 10 Jun 2025 | Direct | |||
| Larry L. Wood | PRCT | Common Stock | Award | 34.7% | 1,538 | 5,968 | 10 Jun 2025 | Direct | ||
| Larry L. Wood | PRCT | Stock Option (Right to Buy) | Award | 2,771 | 2,771 | 10 Jun 2025 | Direct | |||
| Taylor C. Harris | PRCT | Common Stock | Award | 1.58% | 1,538 | 99,176 | 10 Jun 2025 | Direct | ||
| Taylor C. Harris | PRCT | Stock Option (Right to Buy) | Award | 2,771 | 2,771 | 10 Jun 2025 | Direct | |||
| Mary Garrett | PRCT | Common Stock | Award | 12% | 1,538 | 14,385 | 10 Jun 2025 | Direct | ||
| Mary Garrett | PRCT | Stock Option (Right to Buy) | Award | 2,771 | 2,771 | 10 Jun 2025 | Direct | |||
| Amy M. Dodrill | PRCT | Common Stock | Award | 25.3% | 1,538 | 7,626 | 10 Jun 2025 | Direct | ||
| Amy M. Dodrill | PRCT | Stock Option (Right to Buy) | Award | 2,771 | 2,771 | 10 Jun 2025 | Direct | |||
| Thomas M. Prescott | PRCT | Common Stock | Award | 65.2% | 1,538 | 3,896 | 10 Jun 2025 | Direct | ||
| Thomas M. Prescott | PRCT | Stock Option (Right to Buy) | Award | 2,771 | 2,771 | 10 Jun 2025 | Direct | |||
| Hisham Shiblaq | PRCT | Common Stock | Sale | -24.1% | $1,282,637 | $64.13 | -20,000 | 63,133 | 06 Jun 2025 | Direct |
| Hisham Shiblaq | PRCT | Common Stock | Options Exercise | 31.7% | 20,000 | 83,133 | 06 Jun 2025 | Direct | ||
| Hisham Shiblaq | PRCT | Stock Option (Right to Buy) | Options Exercise | -63.3% | -20,000 | 11,578 | 06 Jun 2025 | Direct | ||
| Mr. Antal Rohit Desai | PRCT | Common Stock | Sale | -21.9% | $1,619,830 | $64.79 | -25,000 | 89,363 | 05 Jun 2025 | By The 2:22 DNA Trust |
| Mr. Antal Rohit Desai | PRCT | Common Stock | Sale | -17.9% | $1,525,556 | $61.02 | -25,000 | 114,363 | 04 Jun 2025 | By The 2:22 DNA Trust |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.